Lansoprazole Delayed-Release Capsules and Mogamulizumab
Determining the interaction of Lansoprazole Delayed-Release Capsules and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lansoprazole
Brand name: FIRST Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab
Synonyms: Lansoprazole
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lansoprazole Delayed-Release Capsules-Mogamulizumab-kpkc
- Lansoprazole Delayed-Release Capsules-Mogamulizumab-kpkc Intravenous
- Lansoprazole Delayed-Release Capsules-Molindone
- Lansoprazole Delayed-Release Capsules-Mometasone (Oral Inhalation)
- Lansoprazole Delayed-Release Capsules-Mometasone and Formoterol
- Lansoprazole Delayed-Release Capsules-Mometasone and formoterol Inhalation
- Mogamulizumab-Lansoprazole Orally Disintegrating Tablets
- Mogamulizumab-Lansoprazole, Amoxicillin, and Clarithromycin
- Mogamulizumab-Lanthanum
- Mogamulizumab-Lanthanum carbonate
- Mogamulizumab-Lanthanum Carbonate Tablets
- Mogamulizumab-Lanthanum Chewable Tablets